Piperine Inhibits TGF-β Signaling Pathways and Disrupts EMT-Related Events in Human Lung Adenocarcinoma Cells
Overview
Authors
Affiliations
Piperine, an amide extracted from the Piper spices, exhibits strong anti-tumor properties. However, its effect on the epithelial-mesenchymal transition (EMT) process has never been investigated. Herein, we evaluate the toxic effect of piperine on lung adenocarcinoma (A549), breast adenocarcinoma (MDA-MB-231) and hepatocellular carcinoma (HepG2) cell lines, as well as its ability to inhibit EMT-related events induced by TGF-β1 treatment. The cell viability was investigated by MTT assay. Protein expression was evaluated by Western blot. Gene expression was monitored by real-time PCR. Zymography assay was employed to detect metalloproteinase (MMP) activity in conditioned media. Cell motility was assessed by the wound-healing and phagokinetic gold sol assays. The results revealed that piperine was cytotoxic in concentrations over 100 µM, showing IC50 values for HepG2, MDA-MB-231 and A549 cell lines of 214, 238 and 198 µM, respectively. In order to investigate whether piperine would reverse the TGF-β1 induced-EMT, the A549 cell line was pretreated with sublethal concentrations of the natural amide followed by the addition of TGF-β1. Besides disrupting EMT-related events, piperine also inhibited both ERK 1/2 and SMAD 2 phosphorylation. These results suggest that piperine might be further used in therapeutic strategies for metastatic cancer and EMT-related disorders.
Effat H, El Houseini M, Abohashem R Indian J Clin Biochem. 2025; 40(1):32-45.
PMID: 39835241 PMC: 11741974. DOI: 10.1007/s12291-024-01212-0.
Hakeem A, El-Kersh D, Hammam O, Elhosseiny A, Zaki A, Kamel K Sci Rep. 2024; 14(1):18181.
PMID: 39107323 PMC: 11303729. DOI: 10.1038/s41598-024-65508-0.
Gusson-Zanetoni J, Cardoso L, de Sousa S, de Melo Moreira Silva L, de Oliveira Martinho J, Henrique T Int J Mol Sci. 2024; 25(11).
PMID: 38891950 PMC: 11172343. DOI: 10.3390/ijms25115762.
Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors.
Runa F, Ortiz-Soto G, de Barros N, Kelber J Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543112 PMC: 10975212. DOI: 10.3390/ph17030326.
Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds.
Choudhary N, Bawari S, Burcher J, Sinha D, Tewari D, Bishayee A Cancers (Basel). 2023; 15(15).
PMID: 37568796 PMC: 10417502. DOI: 10.3390/cancers15153980.